Clonazepam
Company: Watson Pharmaceuticals
Approval Status: Approved January 1998
Treatment for: anticonvulsant
Areas: Neurology
General Information
Other Useful Resources
Clonazepam has been approved as an anticonvulsant to be manufactured in 0.5mg, 1mg and 2mg tablets. It is the generic equivalent of Roche Laboratories' Klonopin.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
